Objective Asthma affects the quality of life of millions of sufferers globally and causes a huge economic burden each year; asthma treatment is estimated to cost €17.7bn and the cost of lost productivity €9.8bn. It is estimated that in Europe there are 30 million asthma sufferers and 15,000 will die each year from an asthma attack even though the drugs used to treat asthma are safe, effective and if used correctly, would prevent many of these deaths. Asthma attacks result from ineffective monitoring leading to inadequate doses of prescribed drugs and therefore poor control of symptoms. Monitoring is vital as asthmatics will often not notice a gradual worsening of symptoms and will not adjust their medication accordingly potentially leading to a severe attack. Peak flow meters are currently used by asthmatics to monitor symptoms on a regular basis but compliance is poor as they are difficult to use, particularly in the young or old, and the technique required can cause exacerbation of symptoms plus the output then requires interpretation. We have developed a prototype of our easy to use home monitoring device that uses normal tidal breathing to generate breath profiles that change as symptoms deteriorate. The device incorporates our patented sensor housed in the mouth piece, which captures the breath profiles, attached to a handheld screen to display the interpretation of the breath profiles using an easy to understand traffic light system. Patients can then easily see whether they need to increase their asthma medication to control their symptoms and avoid an asthma attack. This Phase 1 project will assess the feasibility of device development and commercialisation including the clinical and regulatory requirements for CE marking. Fields of science natural sciencescomputer and information sciencessoftwaremedical and health sciencesclinical medicinepneumologyasthmamedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugssocial scienceseconomics and businesseconomicsproduction economicsproductivityengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensors Programme(s) H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being Main Programme H2020-EU.3.1.3. - Treating and managing disease Topic(s) PHC-12-2015-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-1-2015 Funding Scheme SME-1 - SME instrument phase 1 Coordinator ANAXSYS TECHNOLOGY LIMITED Net EU contribution € 50 000,00 Address Med ic4 keele science park ST5 5NL Keele newcastle staffordshire United Kingdom See on map Region West Midlands (England) Shropshire and Staffordshire Staffordshire CC Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00